Fighting Falsified Medicines with Paperwork – A Historic Review of Danish Legislation Governing Distribution of Medicines

Research output: Contribution to journalJournal articlepeer-review

Standard

Fighting Falsified Medicines with Paperwork – A Historic Review of Danish Legislation Governing Distribution of Medicines. / Borup, Rasmus; Kaae, Susanne; Minssen, Timo; Traulsen, Janine Marie.

In: Journal of Pharmaceutical Policy and Practice, Vol. 30, No. 9, 06.10.2016, p. 1-8.

Research output: Contribution to journalJournal articlepeer-review

Harvard

Borup, R, Kaae, S, Minssen, T & Traulsen, JM 2016, 'Fighting Falsified Medicines with Paperwork – A Historic Review of Danish Legislation Governing Distribution of Medicines', Journal of Pharmaceutical Policy and Practice, vol. 30, no. 9, pp. 1-8. https://doi.org/10.1186/s40545-016-0078-2

APA

Borup, R., Kaae, S., Minssen, T., & Traulsen, J. M. (2016). Fighting Falsified Medicines with Paperwork – A Historic Review of Danish Legislation Governing Distribution of Medicines. Journal of Pharmaceutical Policy and Practice, 30(9), 1-8. https://doi.org/10.1186/s40545-016-0078-2

Vancouver

Borup R, Kaae S, Minssen T, Traulsen JM. Fighting Falsified Medicines with Paperwork – A Historic Review of Danish Legislation Governing Distribution of Medicines. Journal of Pharmaceutical Policy and Practice. 2016 Oct 6;30(9):1-8. https://doi.org/10.1186/s40545-016-0078-2

Author

Borup, Rasmus ; Kaae, Susanne ; Minssen, Timo ; Traulsen, Janine Marie. / Fighting Falsified Medicines with Paperwork – A Historic Review of Danish Legislation Governing Distribution of Medicines. In: Journal of Pharmaceutical Policy and Practice. 2016 ; Vol. 30, No. 9. pp. 1-8.

Bibtex

@article{8bb34ccd4405440d997ffe1c60ae3ca5,
title = "Fighting Falsified Medicines with Paperwork – A Historic Review of Danish Legislation Governing Distribution of Medicines",
abstract = "Many areas of pharmaceutical legislation in the European Union (EU) are harmonised in order to promote the internal market and protect public health. Ideally, harmonisation leads to less fragmented regulation and cross-border complexities. This study, however, focuses on an increasingly harmonised legislative area that is subject to increases in requirements and complexities: the distribution of medicines. This study compared Danish legislation governing the distribution of medicines before and after Denmark joined the EU in order to assess the impact of EU harmonisation, as well as to evaluate whether the drastic increases in requirements mandated by the Falsified Medicines Directive of 2011 correspond to a new approach to governing the pharmaceutical supply chain. ",
keywords = "Faculty of Law, Pharmaceutical policy, risk management, regulation, legislation, Europe, , Falsified Medicines Directive",
author = "Rasmus Borup and Susanne Kaae and Timo Minssen and Traulsen, {Janine Marie}",
year = "2016",
month = oct,
day = "6",
doi = "10.1186/s40545-016-0078-2",
language = "English",
volume = "30",
pages = "1--8",
journal = "Journal of Pharmaceutical Policy and Practice",
issn = "2052-3211",
publisher = "BioMed Central Ltd.",
number = "9",

}

RIS

TY - JOUR

T1 - Fighting Falsified Medicines with Paperwork – A Historic Review of Danish Legislation Governing Distribution of Medicines

AU - Borup, Rasmus

AU - Kaae, Susanne

AU - Minssen, Timo

AU - Traulsen, Janine Marie

PY - 2016/10/6

Y1 - 2016/10/6

N2 - Many areas of pharmaceutical legislation in the European Union (EU) are harmonised in order to promote the internal market and protect public health. Ideally, harmonisation leads to less fragmented regulation and cross-border complexities. This study, however, focuses on an increasingly harmonised legislative area that is subject to increases in requirements and complexities: the distribution of medicines. This study compared Danish legislation governing the distribution of medicines before and after Denmark joined the EU in order to assess the impact of EU harmonisation, as well as to evaluate whether the drastic increases in requirements mandated by the Falsified Medicines Directive of 2011 correspond to a new approach to governing the pharmaceutical supply chain.

AB - Many areas of pharmaceutical legislation in the European Union (EU) are harmonised in order to promote the internal market and protect public health. Ideally, harmonisation leads to less fragmented regulation and cross-border complexities. This study, however, focuses on an increasingly harmonised legislative area that is subject to increases in requirements and complexities: the distribution of medicines. This study compared Danish legislation governing the distribution of medicines before and after Denmark joined the EU in order to assess the impact of EU harmonisation, as well as to evaluate whether the drastic increases in requirements mandated by the Falsified Medicines Directive of 2011 correspond to a new approach to governing the pharmaceutical supply chain.

KW - Faculty of Law

KW - Pharmaceutical policy, risk management

KW - regulation, legislation, Europe,

KW - Falsified Medicines Directive

UR - http://joppp.biomedcentral.com/articles/10.1186/s40545-016-0078-2

U2 - 10.1186/s40545-016-0078-2

DO - 10.1186/s40545-016-0078-2

M3 - Journal article

C2 - 27713830

VL - 30

SP - 1

EP - 8

JO - Journal of Pharmaceutical Policy and Practice

JF - Journal of Pharmaceutical Policy and Practice

SN - 2052-3211

IS - 9

ER -

ID: 141957728